Nifty
Sensex
:
:
17274.30
58065.47
386.95 (2.29%)
1276.66 (2.25%)

Pharmaceuticals & Drugs

Rating :
47/99

BSE: 524824 | NSE: BALPHARMA

94.10
04-Oct-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 95.10
  • 95.75
  • 93.35
  • 94.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  11275
  •  10.64
  •  148.85
  •  85.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 146.85
  • 34.56
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 245.09
  • 1.06%
  • 2.39

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.00%
  • 0.00%
  • 31.45%
  • FII
  • DII
  • Others
  • 0.3%
  • 0.00%
  • 16.25%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.60
  • 6.09
  • 18.01

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.26
  • 6.69
  • 36.71

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.20
  • 14.99
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.95
  • 27.54
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.90
  • 1.82
  • 1.92

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.70
  • 12.34
  • 12.96

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
69.84
70.83
-1.40%
74.05
70.81
4.58%
69.17
63.03
9.74%
67.17
64.56
4.04%
Expenses
64.81
63.34
2.32%
70.60
64.46
9.53%
62.95
57.10
10.25%
60.85
57.46
5.90%
EBITDA
5.03
7.49
-32.84%
3.45
6.35
-45.67%
6.22
5.93
4.89%
6.33
7.10
-10.85%
EBIDTM
7.21%
10.57%
4.65%
8.97%
8.99%
9.41%
9.42%
11.00%
Other Income
0.24
0.14
71.43%
3.70
0.73
406.85%
0.75
0.19
294.74%
0.56
0.06
833.33%
Interest
2.37
2.97
-20.20%
2.45
3.11
-21.22%
2.36
2.89
-18.34%
2.63
3.19
-17.55%
Depreciation
2.23
2.19
1.83%
2.42
3.44
-29.65%
2.21
2.03
8.87%
2.21
2.17
1.84%
PBT
0.68
2.46
-72.36%
2.28
0.53
330.19%
2.40
1.20
100.00%
2.04
1.81
12.71%
Tax
0.40
0.81
-50.62%
0.09
-3.00
-
1.93
0.80
141.25%
0.65
1.31
-50.38%
PAT
0.28
1.65
-83.03%
2.19
3.53
-37.96%
0.47
0.40
17.50%
1.40
0.50
180.00%
PATM
0.41%
2.33%
2.95%
4.99%
0.68%
0.64%
2.08%
0.77%
EPS
0.19
1.09
-82.57%
1.33
2.41
-44.81%
0.43
0.22
95.45%
0.93
0.30
210.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Net Sales
280.23
281.21
250.53
171.09
225.01
209.29
228.91
198.32
187.16
178.87
114.29
Net Sales Growth
4.09%
12.25%
46.43%
-23.96%
7.51%
-8.57%
15.42%
5.96%
4.63%
56.51%
 
Cost Of Goods Sold
162.51
155.74
140.87
75.74
104.04
88.57
103.94
94.06
87.49
83.74
54.71
Gross Profit
117.72
125.48
109.66
95.35
120.96
120.71
124.97
104.25
99.67
95.14
59.58
GP Margin
42.01%
44.62%
43.77%
55.73%
53.76%
57.68%
54.59%
52.57%
53.25%
53.19%
52.13%
Total Expenditure
259.21
257.24
225.88
166.07
207.33
191.95
214.10
183.46
170.05
161.00
104.36
Power & Fuel Cost
-
5.89
4.98
4.76
6.38
6.07
6.17
4.66
4.54
4.39
2.90
% Of Sales
-
2.09%
1.99%
2.78%
2.84%
2.90%
2.70%
2.35%
2.43%
2.45%
2.54%
Employee Cost
-
47.25
41.88
50.44
50.28
52.16
45.37
37.30
32.24
28.12
20.58
% Of Sales
-
16.80%
16.72%
29.48%
22.35%
24.92%
19.82%
18.81%
17.23%
15.72%
18.01%
Manufacturing Exp.
-
21.92
18.62
15.80
20.28
18.03
21.44
19.80
20.78
18.23
11.24
% Of Sales
-
7.79%
7.43%
9.23%
9.01%
8.61%
9.37%
9.98%
11.10%
10.19%
9.83%
General & Admin Exp.
-
8.07
5.47
7.48
9.27
11.21
16.82
13.98
12.43
11.54
5.41
% Of Sales
-
2.87%
2.18%
4.37%
4.12%
5.36%
7.35%
7.05%
6.64%
6.45%
4.73%
Selling & Distn. Exp.
-
14.86
10.28
10.61
15.74
15.63
19.50
13.18
11.91
13.49
8.73
% Of Sales
-
5.28%
4.10%
6.20%
7.00%
7.47%
8.52%
6.65%
6.36%
7.54%
7.64%
Miscellaneous Exp.
-
3.51
3.79
1.23
1.33
0.27
0.86
0.47
0.65
1.48
8.73
% Of Sales
-
1.25%
1.51%
0.72%
0.59%
0.13%
0.38%
0.24%
0.35%
0.83%
0.68%
EBITDA
21.03
23.97
24.65
5.02
17.68
17.34
14.81
14.86
17.11
17.87
9.93
EBITDA Margin
7.50%
8.52%
9.84%
2.93%
7.86%
8.29%
6.47%
7.49%
9.14%
9.99%
8.69%
Other Income
5.25
5.15
1.14
1.85
1.01
1.73
3.04
1.28
1.17
0.65
0.79
Interest
9.81
10.91
12.16
12.73
12.74
9.41
8.49
6.48
6.52
7.16
6.79
Depreciation
9.07
9.04
9.52
7.68
6.16
6.77
6.49
7.01
7.02
4.74
2.90
PBT
7.40
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
1.04
Tax
3.07
3.48
-0.61
-0.64
-2.36
2.51
3.27
2.39
1.19
1.55
0.63
Tax Rate
41.49%
37.91%
-14.88%
4.73%
1180.00%
87.15%
113.94%
90.19%
25.11%
23.38%
60.58%
PAT
4.34
5.61
4.74
-12.22
3.79
2.79
1.75
1.41
3.62
5.07
0.41
PAT before Minority Interest
4.26
5.70
4.71
-12.89
2.15
0.38
-0.40
0.26
3.55
5.07
0.41
Minority Interest
-0.08
-0.09
0.03
0.67
1.64
2.41
2.15
1.15
0.07
0.00
0.00
PAT Margin
1.55%
1.99%
1.89%
-7.14%
1.68%
1.33%
0.76%
0.71%
1.93%
2.83%
0.36%
PAT Growth
-28.62%
18.35%
-
-
35.84%
59.43%
24.11%
-61.05%
-28.60%
1,136.59%
 
EPS
2.78
3.60
3.04
-7.83
2.43
1.79
1.12
0.90
2.32
3.25
0.26

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Shareholder's Funds
58.63
53.58
52.43
66.64
64.99
62.45
54.90
55.20
50.05
36.18
Share Capital
14.82
14.82
14.17
14.17
14.17
14.17
12.87
12.87
11.11
10.48
Total Reserves
42.87
37.82
38.25
52.47
50.82
48.27
40.01
40.31
37.20
25.50
Non-Current Liabilities
36.40
34.19
33.56
37.85
45.57
30.02
45.12
16.34
17.92
64.54
Secured Loans
27.01
23.93
22.93
28.76
33.25
12.76
15.24
6.11
6.58
53.76
Unsecured Loans
0.00
0.00
0.22
0.00
1.43
5.04
19.71
0.53
1.39
3.97
Long Term Provisions
4.69
4.07
3.62
2.71
2.05
3.42
2.28
1.65
1.06
0.00
Current Liabilities
165.65
152.53
159.49
163.24
154.40
143.24
111.19
92.36
86.77
34.59
Trade Payables
65.56
47.17
38.67
47.34
49.96
54.43
46.85
38.53
33.53
27.02
Other Current Liabilities
24.21
23.57
30.69
27.86
33.77
16.45
12.01
11.86
8.66
6.03
Short Term Borrowings
70.75
80.82
89.63
87.08
68.31
71.07
50.09
40.14
42.75
0.00
Short Term Provisions
5.12
0.98
0.50
0.96
2.37
1.29
2.24
1.83
1.83
1.53
Total Liabilities
260.55
240.07
238.38
261.31
260.17
233.33
211.03
163.87
154.74
135.31
Net Block
67.39
68.59
70.71
70.39
71.48
59.98
56.23
52.20
55.18
54.26
Gross Block
111.14
105.10
97.70
89.76
84.71
66.44
106.10
95.14
90.11
76.86
Accumulated Depreciation
43.75
36.52
27.00
19.37
13.23
6.46
49.87
42.95
34.93
22.60
Non Current Assets
75.96
75.93
81.02
78.26
75.41
68.78
68.03
58.74
59.63
54.40
Capital Work in Progress
1.61
0.00
3.32
3.63
0.21
1.70
3.93
0.77
0.25
0.13
Non Current Investment
0.00
0.00
0.00
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
5.01
4.86
5.43
1.69
3.15
6.61
7.54
5.42
3.95
0.00
Other Non Current Assets
1.95
2.49
1.56
2.54
0.55
0.46
0.32
0.34
0.24
0.00
Current Assets
184.57
164.15
157.37
183.05
184.77
164.55
143.00
105.12
95.12
80.90
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
74.40
60.39
67.71
69.75
66.49
54.73
41.75
35.82
31.71
32.21
Sundry Debtors
75.31
67.20
49.60
64.70
64.05
61.80
56.94
44.98
45.49
37.02
Cash & Bank
5.39
3.85
3.13
4.32
4.15
4.71
4.63
5.49
3.02
2.23
Other Current Assets
29.47
4.69
4.07
0.70
50.07
43.31
39.66
18.83
14.89
9.44
Short Term Loans & Adv.
17.21
28.02
32.85
43.58
49.83
42.45
38.45
17.48
13.96
5.56
Net Current Assets
18.93
11.61
-2.12
19.81
30.36
21.31
31.81
12.77
8.35
46.31
Total Assets
260.53
240.08
238.39
261.31
260.18
233.33
211.03
163.86
154.75
135.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Cash From Operating Activity
27.71
22.34
23.24
7.76
0.58
6.31
-19.35
14.53
13.31
4.61
PBT
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
1.04
Adjustment
18.29
21.14
19.01
17.41
15.14
14.79
11.46
11.69
10.43
9.49
Changes in Working Capital
1.69
-2.80
17.94
-7.07
-16.18
-9.95
-32.66
-0.59
-2.59
-6.10
Cash after chg. in Working capital
29.16
22.45
23.42
10.13
1.84
7.72
-18.55
15.84
14.47
4.43
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.45
-0.11
-0.17
-2.38
-1.27
-1.40
-0.80
-1.31
-1.16
0.18
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-9.48
-5.53
-4.71
-8.04
-3.56
-7.96
-13.88
-5.30
-7.30
-1.59
Net Fixed Assets
-7.15
-3.66
-6.22
-4.61
-3.80
41.86
-12.93
-5.24
-15.62
-2.86
Net Investments
0.00
-0.98
0.02
0.00
-7.42
1.16
-0.09
-1.07
0.04
0.00
Others
-2.33
-0.89
1.49
-3.43
7.66
-50.98
-0.86
1.01
8.28
1.27
Cash from Financing Activity
-18.13
-16.63
-19.97
0.01
3.53
-5.94
32.37
-6.80
-7.52
-2.40
Net Cash Inflow / Outflow
0.09
0.17
-1.44
-0.27
0.55
-7.58
-0.86
2.43
-1.51
0.62
Opening Cash & Equivalents
1.02
0.86
2.44
2.71
2.16
-17.72
5.49
3.02
4.53
1.61
Closing Cash & Equivalent
1.11
1.02
0.86
2.44
2.71
-25.30
4.63
5.45
3.02
2.23

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Book Value (Rs.)
38.92
35.52
36.99
47.02
45.86
44.06
41.09
41.32
43.48
34.33
ROA
2.28%
1.97%
-5.16%
0.83%
0.15%
-0.18%
0.14%
2.23%
3.50%
0.31%
ROE
10.34%
8.97%
-21.65%
3.27%
0.59%
-0.69%
0.49%
7.00%
12.03%
1.14%
ROCE
12.33%
9.72%
-0.44%
6.88%
7.45%
7.59%
7.35%
10.88%
14.05%
8.51%
Fixed Asset Turnover
2.60
2.47
1.83
2.58
2.80
2.72
2.01
2.06
2.18
1.60
Receivable days
92.48
85.08
121.92
104.42
108.60
92.23
91.87
86.58
82.73
104.23
Inventory Days
87.47
93.31
146.63
110.50
104.61
74.94
69.91
64.63
64.10
91.99
Payable days
132.11
111.21
90.28
86.70
99.47
88.16
89.31
79.05
72.93
89.00
Cash Conversion Cycle
47.85
67.18
178.27
128.22
113.74
79.02
72.47
72.17
73.90
107.22
Total Debt/Equity
1.80
2.09
2.26
1.85
1.69
1.49
1.68
0.93
1.08
1.60
Interest Cover
1.84
1.34
-0.06
0.98
1.31
1.34
1.41
1.73
1.93
1.15

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.